IINN
Inspira Technologies Oxy B.H.N. Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$1.05
−0.94%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- -16.1%
- EBIT
- +207.5%
- EPS
- +28.7%
- Free cash flow
- -100.0%
- Operating cash flow
- -100.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -4.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025